At Clinovo, we are more than just a service provider; we are a strategic partner dedicated to revolutionizing clinical research and drug development. We understand the immense pressures and costs involved in bringing life-changing therapies to patients.
With delays and inefficiencies costing sponsors as much as between $600,000 and $8 million per day when factoring in lost revenue and opportunity cost, the need for transformative clinical trial solutions is critical. .
Clinovo directly addresses these challenges by empowering pharmaceutical and biotech companies to overcome inefficiencies and accelerate innovation in clinical development through our AI-driven precision and workforce optimization solutions.
Our core mission is to deliver unparalleled efficiency and precision in clinical trials. We achieve this by fundamentally transforming how you deploy, manage, and empower your talent.
Our strategic workforce optimization approach, amplified by our cutting-edge Agentic Workforce, integrates human expertise with technological advancement for superior outcomes—faster, leaner, smarter clinical trials.
What sets Clinovo apart is our integrated suite of workforce optimization services, meticulously designed to meet the diverse needs of modern clinical trials. We blend deep industry knowledge with proprietary AI to unlock new levels of efficiency thereby significantly accelerating drug development for vital therapies.
Offers a comprehensive suite of clinical development services tailored to trial needs.
Backed by deep domain knowledge in clinical research and trial operations.
Uses proprietary artificial intelligence to streamline processes and improve outcomes.
Vamsi is a seasoned global executive with over 25 years of experience in management consulting and entrepreneurship, spanning South Africa, the United States, and India. His expertise lies in business administration, strategic growth, building high-performing teams, scaling businesses, and executing complex international M&A transactions. He has held key leadership roles at renowned organizations including Deloitte, Pfizer, Johnson & Johnson, and Merrill.
He currently serves as Chairman of both LAXAI, a small molecule CRDMO company, and Clinovo, where he provides strategic oversight and drives strategic initiatives for the companies. In addition, he is a partner at Digilife, an early-stage venture fund that supports technology-driven startups addressing critical challenges in healthcare.
Outside of his professional endeavors, Vamsi is an avid traveler and culinary enthusiast who enjoys immersing himself in diverse cultures. His passion for exploration reflects his dynamic and globally informed perspective in both business and life.
Steve Matas is the CEO of Clinovo, with over 20 years in staffing and outsourcing experience, much of which has been within the field of clinical research. Previously the President of a mid-sized, global CRO, Steve has witnessed first-hand the staggering number of opportunities drug sponsors have to capitalize on efficiencies and technology to reduce timelines, costs and delays within their workflows. As the CEO of Clinovo, Steve is dedicated to bringing these solutions to the market and breaking through the vicious cycle of inefficiencies that plague the industry. With an eye for great talent, Steve has cultivated a team of experienced professionals that also value innovation, quality and progress above the status quo, in order to revolutionize the way research outsourcing is done today and in the future. Steve has been married 20+ years and is blessed with four children and a grandchild. Outside of work, he enjoys the outdoors, golfing, backpacking and chasing the latest bio hack.
With 13+ years of expertise, Matt has a strong background in guiding clients through staff augmentation, workforce optimization, and outsourcing strategy. His journey began in healthcare, transitioning eight years ago to focus on Biopharmaceutical sponsors. Being local to the greater Boston area, he’s particularly enjoyed his involvement in the Northeast Biopharma community, where he actively collaborates with leaders to solve clinical trial execution challenges and helps foster crucial industry connections. Through this involvement, he’s witnessed firsthand how inefficient trial processes—such as an over-reliance on outdated traditional workforce and outsourcing models, suboptimal resource allocation, and a lack of seamless collaboration with CRO partners—not only inflate costs but also directly impede the rapid advancement of innovative treatments.
With over 30 years of experience in the Pharmaceutical, Biotech, and Contract Research Organization (CRO) sectors, Dawn brings a proven track record of success in global clinical trial management across all phases and numerous therapeutic areas. Her expertise encompasses executive-level business operations, including board participation and chairing, alongside the build-up and oversight of clinical operations groups, quality management, and extensive process development and improvement. She also possess deep knowledge of clinical trial management systems and have a consistent record of top-tier performance within major pharmaceutical companies.
Nivedita (Neetha) is a technology executive and multiple-time founder with four successful startup exits. She has deep technology background and vast experience ranging from AI, network technologies, cyber security to virtual reality. Her 20+ years of expeience spans both start-ups and large worldwide enterprises across Silicon Valley and India. Neetha has bootstrapped engineering organizations and executed product roadmaps from inception to its successful market adoption. She has a MS in Computer Science from Stanford University.
At Clinovo, our commitment goes beyond services; we are dedicated to empowering you to achieve significant breakthroughs. By leveraging cutting-edge technology and unparalleled human expertise, we ensure your innovations reach the patients faster, leaner, and smarter, who need them most. We are striving to be a global leader in drug development through accelerating drug development partnerships and providing innovative clinical services.
Our digital solutions for life sciences are focused on saving lives through clinical research. We embody urgent drug development, collaborative clinical research, and accountable clinical trials. Our customer-centric clinical services and commitment to quality clinical research are paramount. Our clinical services leadership, clinical development executive team, life sciences operations expertise, clinical data management leadership, biostatistics leadership, and pharmacovigilance expertise drive our success.
We are constantly monitoring clinical research trends and leveraging real-world evidence (RWE) and data analysis in clinical trials to provide the best solutions for biotechnology, pharmaceutical research, and medical devices companies, as well as other CROs.
